Cadrenal Therapeutics stockholders elect directors and ratify auditor at 2023 annual meeting

Cadrenal Therapeutics, Inc.

Quang Pham re-elected as Class I director with 10,183,242 votes for, 8,560 withheld; Glynn Wilson with 10,139,612 for, 52,190 withheld.
WithumSmith+Brown, P.C. ratified as independent auditor for fiscal 2023 with 11,126,433 for, 10,899 against, 192 abstain.
Quorum achieved with over 34% of 13,022,754 outstanding shares represented at the October 20, 2023 meeting.
Broker non-votes totaled 945,722 for each director election; none for the auditor ratification (routine matter).

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Cadrenal Therapeutics, Inc. shareholders approved Ratification of the appointment of WithumSmith+Brown, P.C. as the Company’s independent registered public accounting firm for the year ending December 31, 2023 at the 2023-10-20 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2023-10-20

Exact text from the filing

Proposal 2 . Ratification of the appointment of WithumSmith+Brown, P.C. as the Company’s independent registered public accounting firm for the year ending December 31, 2023 . The stockholders ratified and approved the appointment of WithumSmith+Brown, P.C. as the Company’s independent registered public accounting firm for the year ending December 31, 2023 based on the votes listed below: Votes For Votes Against Abstentions Broker Non-Votes 11,126,433 10,899 192 0

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Cadrenal Therapeutics, Inc. shareholders approved Election of Directors at the 2023-10-20 meeting.

Proposal: director election
Outcome: passed
Meeting: 2023-10-20

Exact text from the filing

Proposal 1 . Election of Directors . The following two (2) individuals were elected as Class I directors, to serve until the Company’s 2026 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified with the following votes: Name of Director Votes For Withheld Broker Non-Votes Quang Pham 10,183,242 8,560 945,722 Glynn Wilson 10,139,612 52,190 945,722

View on SEC.gov

Browse all shareholder votes →

Cadrenal Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001013762-23-005859

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.